Travere Therapeutics, Inc.

NASDAQ:TVTX

14.35 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017201620152014201320122011201020092008
Operating Activities:
Net Income -376.333-278.482-180.091-169.431-146.427-102.678-59.731-47.903117.237-110.938-33.824-30.344-0.015-0.023-0.028-0.018
Depreciation & Amortization 44.93233.07926.61724.57920.40818.66817.80416.13513.3925.4010.2160.12500.0080.0130
Deferred Income Tax -388.65604.1181.99441.29220.345-6.425-22.661-15.573-2.460.07600000
Stock Based Compensation 44.24638.14329.56623.61421.10519.77426.87429.10225.915.91.42517.5630000
Change In Working Capital -25.4750.90479.979-26.0422.6811.0693.8145.473-11.37212.2991.4933.1140.0020.0020.002-0.02
Accounts Receivables -11.264-0.682-0.0592.301-5.1840.1524.945-6.09-4.504-7.959000000
Inventory -39.42-2.064-1.815-5.067-1.958-2.773-1.706-0.306-1.174-0.283000000
Accounts Payables 24.7632.3072.77-6.0369.255-2.7082.6569.6723.37920.3032.8420.6810.0020.0020.002-0.02
Other Working Capital 0.4461.34379.083-17.240.56716.398-2.0812.197-9.0730.237-1.3492.43300-0.0020.02
Other Non Cash Items 421.26519.03123.819102.5432.7287.86425.06718.258-130.13833.94813.0256.8050.0130.012-0.0020.018
Operating Cash Flow -280.021-186.291-14.792-42.743-58.214-24.9587.403-1.596-0.554-45.85-17.589-2.737-0-0.001-0.015-0.018
Investing Activities:
Investments In Property Plant And Equipment -42.259-28.557-24.151-119.845-15.565-19.701-14.009-11.924-7.03-3.964-5.549-1.1930000
Acquisitions Net 109.367019.05113.07815.37-15-13.122-0.5-33.43-29.15-5.4320.0040000
Purchases Of Investments -443.942-385.389-547.076-214.964-223.712-331.345-102.415-184.111-198.53-18.049-6.9900000
Sales Maturities Of Investments 334.575381.993433.604273.482259.14162.755114.526159.529.97713.9938.57900000
Other Investing Activites 98.035-0.6-19.05-113.078-15.37-202.56460.62247.385148.411-0.0933.986-0.510000
Investing Cash Flow 55.776-32.553-137.623-61.32719.863-203.29145.60210.37-80.602-37.263-5.406-1.70000
Financing Activities:
Debt Repayment 0-104.926000-40.20300-45-31.283-0.885-0.0450000
Common Stock Issued 222.23427.108239.887137.4611.61815.89311.73210.021149.4874030.9373.4760000
Common Stock Repurchased 002.1122.04600000-2.257-0.95700000
Dividends Paid 0000000000000000
Other Financing Activities 218.75212.647231.683127.713-3.695272.0665.445-5.694-3.72182.548-0.1131.0070000.025
Financing Cash Flow 218.752117.573231.683127.713-2.077231.8635.445-5.694100.76795.31928.9824.4380000.025
Other Information:
Effect Of Forex Changes On Cash 1.981-2.7941.713-1.307-0.009-0.135-0.0580.117-0.010000000
Net Change In Cash -3.512-104.06580.98122.336-40.4373.47958.3923.19719.60112.2075.9860.001-0-0.001-00.007
Cash At End Of Period 58.17661.688165.75384.77262.436102.87399.39441.00237.80518.2045.9970.0110.0040.0040.0050.005